AFRM vs TPST · P/E 590, rev $3.22B vs $26.3M cap
Affirm Holdings Inc (AFRM) versus Tempest Therapeutics Inc (TPST) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Tempest Therapeutics Inc (TPST) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
TPST does not have a complete income-statement cache yet.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. TPST currently screens at market cap $26.3M.
Not investment advice. Open the AFRM and TPST stock pages for the full models.
Not investment advice.